Olszewski, Carly
Thomson, Sharon
Pring, Kelly
Cox, Siobhan
Merrill, Rebecca
Fishman, Emily
Ambrosini, Alexander
Soltany, Kevin Alexander
Bognet, Gabby
Strauss, Lauren
Graham, Rachel
Guzik, Amy
Strowd, Roy E. http://orcid.org/0000-0001-6651-5267
Article History
Received: 20 December 2021
Revised: 17 April 2022
Accepted: 18 April 2022
First Online: 5 May 2022
Declarations
:
: Carly Olszewski has no relevant financial or non-financial interests to disclose. Sharon Thomson has no relevant financial or non-financial interests to disclose. Kelly Pring has no relevant financial or non-financial interests to disclose. Siobhan Cox has no relevant financial or non-financial interests to disclose. Rebecca Merrill has no relevant financial or non-financial interests to disclose. Emily Fishman has no relevant financial or non-financial interests to disclose. Alexander Ambrosini has no relevant financial or non-financial interests to disclose. K. Alexander Soltany has no relevant financial or non-financial interests to disclose. Gabby Bognet has no relevant financial or non-financial interests to disclose. Dr. Lauren D. Strauss has no relevant financial or non-financial interests to disclose. Rachel Graham has no relevant financial or non-financial interests to disclose. Dr. Amy Guzik has no relevant financial or non-financial interests to disclose. Dr. Roy E. Strowd serves as a consultant for Monteris Medical Inc., Novocure, and Nanobiotix. He receives an editorial stipend as Deputy Section Editor of the Resident and Fellow Section of Neurology<sup>®</sup> and has received research/grant support from the American Academy of Neurology, American Society for Clinical Oncology, Southeastern Brain Tumor Foundation, and Jazz Pharmaceuticals.
Free to read: This content has been made available to all.